VA Healthcare & Services Contracts — September 22, 2026

QTC Medical Services Inc., a Leidos subsidiary, won a $240.6 million firm-fixed-price delivery order from the VA for medical evaluation/screening services under full and open competition, with $233.6 million (97%) already outlayed, indicating strong execution and revenue recognition. This competitive win (no set-aside) bolsters Leidos' civilian healthcare services backlog, though the one-year term limits its revenue contribution to FY24.

Leidos' QTC Medical derives significant revenue from a single agency (VA) for medical evaluation services, with this $240.6 million contract representing 100% of the digest's total value. Any VA budget cuts, procurement pauses, or recompete loss could materially impact this revenue stream, especially given the contract's one-year duration and no options.

The contract's 97% outlay rate ($233.6M of $240.6M) suggests near-complete funding utilization, but the remaining ~$7M could face execution risk if service delivery issues arise. Additionally, the firm-fixed-price structure transfers cost overrun risk to QTC/Leidos, though medium pricing risk indicates manageable exposure.

The VA's sustained spending on medical evaluation services (evidenced by this $240.6M award) suggests a stable or growing civilian healthcare services budget. Leidos/QTC can leverage this contract's performance to bid on follow-on task orders or new VA medical evaluation contracts, potentially expanding its civilian healthcare footprint.

The VA's $240.6 million award to QTC Medical for physician-based evaluation/screening services (NAICS 621111) highlights the agency's consistent investment in healthcare delivery, independent of defense budget cycles. This contract, with no set-aside, indicates a competitive market for medical evaluation services, favoring incumbents with proven performance.

{"entity" => "Leidos Holdings (LDOS)", "reason" => "QTC Medical's $240.6M VA contract is a competitive win but represents a one-year, non-optioned revenue stream; the follow-on procurement is critical to sustaining this revenue.", "trigger" => "VA recompete announcement for medical evaluation services (expected post-Sep 2024) or new task order awards under existing IDIQs"}

{"entity" => "VA Healthcare Services Sector", "reason" => "This contract signals stable VA spending on medical evaluations, but the sector's growth depends on budget appropriations and CR resolutions.", "trigger" => "VA FY2025 budget approval or CR passage; any NDAA or appropriations bill impacting VA healthcare funding"}